# Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in Family Medicine and Geriatric Medicine Outpatient Clinics

> **NCT07069647** · NA · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 4300 (estimated)

## Conditions studied

- Age-Related Macular Degeneration (AMD)
- Diabetic Retinopathy (DR)

## Interventions

- **OTHER:** VeriSee AI-assisted screening tools for diabetic retinopathy and age-related macular degeneration
- **OTHER:** Standard fundus photography with physician interpretation

## Key facts

- **NCT ID:** NCT07069647
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-02
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 4300 (ESTIMATED)
- **Last updated:** 2025-11-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07069647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07069647, "Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in Family Medicine and Geriatric Medicine Outpatient Clinics". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07069647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
